Ipratropium Bromide/Salbutamol Neutec

Ipratropium bromide / Salbutamol, the active ingredient in Ipratropium Bromide/Salbutamol Neutec, is an anticholinergic and β2‑adrenergic agonist presented as a combination inhalation solution for inhalation use. It provides rapid relief of bronchospasm in patients with asthma and chronic obstructive pulmonary disease (COPD) and is commonly used as a rescue medication for acute airway constriction.

GNH USA supplies Ipratropium Bromide/Salbutamol Neutec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing regulatory support for importers.

Ipratropium bromide/salbutamol is a bronchodilator used to manage airway obstruction in respiratory diseases.

Asthma: rapid relief of bronchospasm and improvement of airflow. COPD: relief of bronchospasm and reduction of dyspnea. Acute bronchospasm: prompt bronchodilation during sudden airway constriction episodes.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Throat irritation: local discomfort after inhalation. - Cough: transient irritation of the airway. - Tremor: mild muscle shaking, especially of the hands. - Headache: occasional mild headache. - Palpitations: sensation of rapid or irregular heartbeat.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of airway constriction. - Tachycardia: significant increase in heart rate. - Arrhythmia: irregular heart rhythm. - Angioedema: swelling of face, lips, or throat. - Hypersensitivity reactions: rash, itching, or anaphylaxis. - Severe hypokalemia: low potassium levels, especially with high salbutamol doses.

Before using this inhalation product, consider the following precautions: - Assess cardiovascular status: monitor heart rate and blood pressure. - Evaluate for hypersensitivity: avoid if known allergy to either component. - Caution in patients with arrhythmias: salbutamol may exacerbate rhythm disorders. - Use with care in severe COPD: monitor for worsening respiratory status. - Avoid overdose: follow prescriber instructions closely. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Ipratropium bromide/salbutamol may interact with other medicines. Review the following:

Major Interactions (Avoid): - Non‑selective beta‑blockers: may reduce bronchodilator effect. - MAO inhibitors: increased risk of cardiovascular side effects. - Diuretics (e.g., furosemide): may potentiate hypokalemia with salbutamol. - Tricyclic antidepressants: heightened risk of tachycardia. - Other anticholinergic agents: additive dry‑mouth and urinary retention.

Moderate Interactions (Monitor Closely): - Theophylline: possible additive stimulant effect on the heart. - Sympathomimetic drugs: increased risk of tremor and palpitations. - ACE inhibitors: monitor for cough and bronchospasm. - Corticosteroids: may mask signs of infection. - Antihistamines: potential additive anticholinergic burden.